EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Laparoscopic visualisation of the ureters using near-infrared fluorescence imaging after retrograde indocyanine green injection in deep infiltrating endometriosis: the LAVIC trial

Cloé Vaineau, Bettina Schlatter, Sara Imboden, Anna-Sophie Villiger, Marietta Gulz, Michael D. Mueller, Franziska Siegenthaler

Archives of Gynecology and Obstetrics · 2026-09-21

DOI: 10.1007/s00404-026-08559-0 ↗
AbstractBibliografische Angaben

Abstract

Abstract Objective To evaluate the feasibility and safety of intraureteral indocyanine green fluorescence for real-time ureter visualisation during laparoscopic surgery for deep infiltrating endometriosis. Materials and methods In this prospective, single-arm feasibility study, premenopausal women undergoing minimally invasive surgery for suspected deep infiltrating endometriosis received bilateral retrograde intraureteral indocyanine green following laparoscopic confirmation of the disease. Near-infrared fluorescence imaging was used for real-time ureteral visualisation. The primary outcome was the rate of successful ureteral visualisation. Secondary outcomes included fluorescence characteristics, the extent of ureterolysis, and procedure-related adverse events. Data were analysed primarily using descriptive statistics, with exploratory analyses performed where appropriate. Results Fifty-one patients with a mean age of 36 years were included. The mean duration of surgery was 217.3 ± 81.1 min. The mean duration of cystoscopy was 7.0 ± 5.0 min, and for intraureteral ICG injection 4.3 ± 3.3 min. Bilateral ureteral fluorescence was achieved in 50 of 51 patients (98%). Visualisation was immediate in all cases and persisted throughout surgery. Ureterolysis was required in 45% of patients. No ureteral injuries or ICG-related complications occurred. Conclusion Intraureteral ICG fluorescence appears feasible for real-time ureteral visualisation during complex surgery for deep infiltrating endometriosis. No adverse events attributable to intraureteral ICG administration were observed; however, its clinical utility requires further evaluation in comparative studies. Trial registration The trial protocol is registered at clinicaltrials.gov, NCT05206279

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →